(Q33984852)

English

Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium (English)

1 reference

Europe PubMed Central

30 July 2017

hypoparathyroidism

1 reference

based on heuristic

inferred from title

author name string

Karen K Winer

1

1 reference

Europe PubMed Central

30 July 2017

Ninet Sinaii

2

1 reference

Europe PubMed Central

30 July 2017

James Reynolds

3

1 reference

Europe PubMed Central

30 July 2017

Donna Peterson

4

1 reference

Europe PubMed Central

30 July 2017

Karen Dowdy

5

1 reference

Europe PubMed Central

30 July 2017

Gordon B Cutler

6

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

14 April 2010

1 reference

Europe PubMed Central

30 July 2017

The Journal of Clinical Endocrinology and Metabolism

1 reference

Europe PubMed Central

30 July 2017

95

1 reference

Europe PubMed Central

30 July 2017

6

1 reference

Europe PubMed Central

30 July 2017

2680-2688

1 reference

Europe PubMed Central

30 July 2017

Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902068

5 July 2018

The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902068

5 July 2018

2000 CDC Growth Charts for the United States: methods and development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902068

5 July 2018

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902068

5 July 2018

Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902068

5 July 2018

Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902068

5 July 2018

Nephrocalcinosis in children and adolescents: sonographic evaluation during long-term treatment with 1,25-dihydroxycholecalciferol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902068

5 July 2018

[Initial experiences with substitution treatment of hypoparathyroidism with synthetic human parathyroid hormone]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902068

5 July 2018

Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902068

29 October 2018

A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902068

29 October 2018

Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902068

29 October 2018

Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/20392870

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypercalciuria associated with long-term administration of calcitriol (1,25-dihydroxyvitamin D3). Action of hydrochlorothiazide

1 reference

https://pubmed.ncbi.nlm.nih.gov/20392870

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D

1 reference

https://pubmed.ncbi.nlm.nih.gov/20392870

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/20392870

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1210/JC.2009-2464

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33984852&oldid=1967069677"